论文信息 - Implementation of cytokines to optimize cancer treatment outcomes. - 字舞流文

Implementation of cytokines to optimize cancer treatment outcomes.

Judith A. Smith

[1] L. Bosserman,et al. Randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia: the 20030125 Study Group Trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2] J. Canon,et al. Randomized, double-blind, active-controlled trial of every-3-week darbepoetin alfa for the treatment of chemotherapy-induced anemia. , 2006, Journal of the National Cancer Institute.

[3] M. Millenson,et al. Cancer- and treatment-related anemia: Clinical Practice Guidelines in Oncology , 2005 .

[4] B. Wiens,et al. First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5] H. Ozer. New directions in the management of chemotherapy-induced neutropenia: Risk models, special populations, and quality of life. , 2003, Seminars in oncology.

[6] R. Rubin,et al. Infection in the organ transplant recipient. An overview. , 1995, Infectious disease clinics of North America.

[7] W Satterlee,et al. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. , 1971, The New England journal of medicine.